Inventor · disambiguated record
David A. Zarling
Also filed as: ZARLING DAVID · ZARLING DAVID A · ZARLING DAVID ALAN
23 granted patents·20 pending applications·3,439 citations·filing 1990–2013
98Inventor score
Files withSTANFORD RES INST INT11PANGENE CORPORATION5DAIKIN IND LTD4COLBY PHARMACEUTICAL COMPANY2SRI2
Top patents by PatentIndex Score
43 records- 0198US6537829B1Up-converting reporters for biological and other assays using laser excitation techniquesSTANFORD RES INST INT·Filed 1999·Granted Mar 25, 2003·235 cites·52 claims
- 0298US5736410AUp-converting reporters for biological and other assays using laser excitation techniquesSTANFORD RES INST INT·Filed 1995·Granted Apr 7, 1998·325 cites·23 claims
- 0398US5674698AUp-converting reporters for biological and other assays using laser excitation techniquesSTANFORD RES INST INT·Filed 1995·Granted Oct 7, 1997·626 cites·36 claims
- 0497US6399397B1Up-converting reporters for biological and other assays using laser excitation techniquesSTANFORD RES INST INT·Filed 2000·Granted Jun 4, 2002·212 cites·18 claims
- 0597US6312914B1Up-converting reporters for biological and other assaysORASURE TECHNOLOGIES INC·Filed 2000·Granted Nov 6, 2001·144 cites·4 claims
- 0697US5698397AUp-converting reporters for biological and other assays using laser excitation techniquesSTANFORD RES INST INT·Filed 1995·Granted Dec 16, 1997·335 cites·11 claims
- 0795US6159686AUp-converting reporters for biological and other assaysSTANFORD RES INST INT·Filed 1998·Granted Dec 12, 2000·169 cites·19 claims
- 0894US6977295B2Locked nucleic acid hybrids and methods of useINVITROGEN CORP·Filed 2000·Granted Dec 20, 2005·153 cites·25 claims
- 0993US5223414AProcess for nucleic acid hybridization and amplificationSTANFORD RES INST INT·Filed 1990·Granted Jun 29, 1993·325 cites·4 claims
- 1091US6074853ASequence alterations using homologous recombinationSRI·Filed 1998·Granted Jun 13, 2000·128 cites·18 claims
- 1190US5891656AUp-converting reporters for biological and other assays using laser excitation techniquesSTANFORD RES INST INT·Filed 1997·Granted Apr 6, 1999·159 cites·6 claims
- 1288US5670316ADiagnostic applications of double D-loop formationDAIKIN IND LTD·Filed 1992·Granted Sep 23, 1997·142 cites·21 claims
- 1387US5273881ADiagnostic applications of double D-loop formationDAIKIN IND LTD·Filed 1991·Granted Dec 28, 1993·173 cites·35 claims
- 1485US5948653ASequence alterations using homologous recombinationFiled 1997·Granted Sep 7, 1999·64 cites·40 claims
- 1584US5763240AIn vivo homologous sequence targeting in eukaryotic cellsSTANFORD RES INST INT·Filed 1994·Granted Jun 9, 1998·85 cites·47 claims
- 1682US6200812B1Sequence alterations using homologous recombinationSTANFORD RES INST INT·Filed 1999·Granted Mar 13, 2001·46 cites·39 claims
- 1777US6255113B1Homologous sequence targeting in eukaryotic cellsSTANFORD RES INST INT·Filed 1995·Granted Jul 3, 2001·31 cites·20 claims
- 1869US5506098AIn situ hybridization methodDAIKIN IND LTD·Filed 1991·Granted Apr 9, 1996·38 cites·11 claims
- 1965US8466130B2Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancersZARLING DAVID A·Filed 2009·Granted Jun 18, 2013·1 cites·3 claims
- 2060US5719023AIn situ hybridization methodDAIKIN IND LTD·Filed 1992·Granted Feb 17, 1998·25 cites·44 claims
- 2157US2004091885A1Use of consensus sequences for targeted homologous gene isolation and recombination in gene familiesPANGENE CORPORATION·Filed 2003·Application pending·0 cites
- 2253US2005214944A1In vivo homologous sequence targeting in cellsZARLING DAVID A·Filed 2004·Application pending·0 cites
- 2352US6576759B2Antisense inhibition of RAD51PANGENE CORPORATION·Filed 1999·Granted Jun 10, 2003·13 cites·2 claims
- 2452US2003105039A1In vivo homologous sequence targeting in cellsFiled 2001·Application pending·0 cites
- 2550US2003229004A1Modulation of tumor cells using BER inhibitors in combination with a sensitizing agent and DSBR inhibitorsPANGENE CORPORATION·Filed 2003·Application pending·0 cites
- 2650US2004019916A1In vivo homologous sequence targeting in eukaryotic cellsFiled 2003·Application pending·0 cites
- 2748US2002032530A1Integrated genomic servicesFiled 2001·Application pending·0 cites
- 2848US2013338110A1Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancersWISCONSIN MED COLLEGE INC·Filed 2013·Application pending·0 cites
- 2946US2003082551A1High-throughput gene cloning and phenotypic screeningFiled 2001·Application pending·0 cites
- 3045US6524856B1Use of consensus sequences for targeted homologous gene isolation and recombination in gene familiesPANGENE CORPORATION·Filed 1998·Granted Feb 25, 2003·10 cites·8 claims
- 3144US2004231010A1Lysozyme transgenic ungulatesFiled 2004·Application pending·0 cites
- 3244US2001044107A1Recombinase mediated gene chip detectionFiled 2000·Application pending·0 cites
- 3343US2002061530A1Enhanced targeting of DNA sequences by recombinase protein and single-stranded homologous DNA probes using DNA analog activationFiled 2001·Application pending·0 cites
- 3442US2006228799A1Use of consensus sequences for targeted homologous gene isolation and recombination in gene familiesPATI SUSHMA·Filed 2005·Application pending·0 cites
- 3541US2004023213A1Domain specific gene evolutionPANGENE CORPORATION·Filed 2001·Application pending·0 cites
- 3640US2002108136A1Transgenic animals produced by homologous sequence targetingSRI·Filed 2001·Application pending·0 cites
- 3738US2003124505A1High-throughput gene cloning and phenotypic screeningFiled 2000·Application pending·0 cites
- 3837US2002086840A1Use of Rad51 inhibitors for p53 gene therapyFiled 2001·Application pending·0 cites
- 3935US2011091931A1Methods and Kits for Determining Oxygen Free Radical (OFR) Levels in Animal and Human Tissues as a Prognostic Marker for Cancer and Other PathophysiologiesCOLBY PHARMACEUTICAL COMPANY·Filed 2010·Application pending·0 cites
- 4030US2010297262A1Pharmaceutically active compositions comprising oxidative stress modulators (osm), new chemical entities, compositions and usesCOLBY PHARMACEUTICAL COMPANY·Filed 2010·Application pending·0 cites
- 4129US2002090361A1In vivo homologous sequence targeting in cellsFiled 1997·Application pending·0 cites
- 4228US9023837B2Androgen induced oxidative stress inhibitorsBASU HIRAK S·Filed 2011·Granted May 5, 2015·0 cites·13 claims
- 4322US2002152494A1Production of recombinant organismsFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David A. Zarling files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →